Filing Details
- Accession Number:
- 0001209191-22-002602
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-01-07 20:23:34
- Reporting Period:
- 2021-12-29
- Accepted Time:
- 2022-01-07 20:23:34
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1610618 | Cidara Therapeutics Inc. | CDTX | Biological Products, (No Disgnostic Substances) (2836) | 461537286 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1751478 | Brady Johnson | 6310 Nancy Ridge Drive San Diego CA 92121 | Vice President, Finance | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-12-29 | 262 | $0.00 | 51,381 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-01-05 | 416 | $1.25 | 50,965 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Restricted Stock Unit | Disposition | 2021-12-29 | 262 | $0.00 | 262 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 262 | 2027-09-17 | No | 4 | M | Direct |
Footnotes
- The Reporting Person was previously granted restricted stock units to vest upon the achievement of certain milestone events that occurred on December 29, 2021.
- Includes 4,000 shares acquired pursuant to the Issuer's Employee Stock Purchase Plan on November 19, 2021.
- Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units on December 29, 2021 and January 1, 2022. These sales are mandated by the Reporting Person's election to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.
- Each restricted stock unit is the economic equivalent of one share of common stock of the Issuer.
- On January 31, 2019, the Reporting Person was granted RSUs totaling 787 shares subject to vesting upon the achievement of various milestones.
Billionaire Hedge Funds
